Guest guest Posted September 29, 2010 Report Share Posted September 29, 2010 Greetings, Here's an update on this subject: CLINICAL QUESTIONS THAT CAN BE ANSWERED ONLY BY CLINICAL TRIALS (A through I) http://bit.ly/cTBymX Question A. Which new treatment is effective when standard treatments are not? Because cancer cells can develop resistance (become refractory) to standard treatment, there's an urgent need to answer this question by testing new agents that target cancer cells in new ways. Patients with refractory cancer urgently need such studies to be completed, and may also benefit early by participating in dose-finding (phase I and II) safety studies. == The goal of this document is to show " what's in it " for patients - that it's not only to advance the science for future patients, but an opportunity to improve our care today. It also provides a section on how study drugs are evaluated, called Evidence 101, which I think is needed in order to reinforce the fact that progress can't be achieved in any other way. Feel free to print and distribute this two-page document as a tri-fold brochure. Perhaps provide a copy for your oncologist! __________________ All the best, Karl Patients Against Lymphoma www.Lymphomation.org Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.